Preventing bowel cancer: An insight for clinicians

Therapeutic Advances in Medical Oncology

Volumn 3, Issue 6, 2011, Pages 269-277

  Hart, Andrew R ^a   Kennedy, Hugh J ^b  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

colorectal cancer; prevention

Indexed keywords

ACETYLSALICYLIC ACID; APC PROTEIN; GUAIAC; HYDROGEN PEROXIDE; K RAS PROTEIN; PROTEIN P53;

ADENOMATOUS POLYP; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PREVENTION; CANCER STAGING; CANCER SURVIVAL; COLONOSCOPY; COLORECTAL CANCER; COMPUTED TOMOGRAPHIC COLONOGRAPHY; DIETARY INTAKE; HUMAN; IMMUNOCHEMISTRY; INCIDENCE; MICROSATELLITE INSTABILITY; OCCULT BLOOD TEST; PHYSICIAN; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SIGMOIDOSCOPY; SURVIVAL RATE; UNITED KINGDOM;

EID: 84856838115     PISSN: 17588340     EISSN: 17588359     Source Type: Journal    
DOI: 10.1177/1758834011419550     Document Type: Review

References (51)

1. Allison J. Tekawa I. Ransom L.A.A. (1996) A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med 334: 155–159.
2. Atkin W. Edwards R. Kralj-Hans I. Wooldrage K. Hart A. Northover J. et al and the UK Flexible Sigmoidoscopy Trial Investigators (2010) Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. The Lancet 375: 1624–1633.
3. Atkin W. Morson B. Cuzick J. (1992) Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med 326: 658–662.
4. Benson V. Patnick J. Davies A. Nadel M. Smith R. Atkin W. (2008) Colorectal cancer screening: A comparison of 35 initiatives in 17 countries. Int J Cancer 122: 1357–1367.
5. Bingham S. Norat T. Moskal A. Ferrari P. Slimani N. Clavel-Chapelon F. et al (2005) Is the association with fibre from foods in colorectal cancer confounded by folate intake?. Cancer Epidemiol Biomarkers Prev 14: 1552–1556.
6. British Society of Gastroenterology and the Association of Coloproctology for Great Britain and Ireland (2010) Guidelines for colorectal cancer screening and surveillance in moderate and high risk group (updated from 2002). Gut 59: 666–690.
7. Cancer Research UK (2008) Cancer Stats – cancer statistics for the UK. http://info.cancerresearchuk.org/ (accessed March 2011).
8. Cole B. Logan R. Halabi S. Benamouzig R. Sandler R. Grainge M. et al (2009) Aspirin for the chemoprevention of colorectal adenomas: Meta-analysis of the randomized trials. JNCI 101: 256–266.
9. Cook N. Lee I. Gaziano J. Gordon D. Ridker P. Manson J. et al (2005) Low-dose aspirin in the primary prevention of cancer:the Women's health study:a randomized controlled trial. J Am Med Assoc 294: 47–55.
10. Cooper K. Squires H. Carroll C. Papaioannou D. Booth A. Logan R. et al (2010) Chemoprevention of colorectal cancer: Systematic review and economic evaluation. Health Technology Assessment 14: 1–205.
11. Cucino C. Buchner A. Sonnenberg A. (2002) Continued rightward shift of colorectal cancer. Dis Colon Rectum 45: 1035–1040.
12. Eaden J. (2004) Review article: Colorectal carcinoma and inflammatory bowel disease. Aliment Pharamacol Ther 20(Suppl. 4): 24–30.
13. Eaden J.A. Abrams K.R. Mayberry J.F. (2001) The risk of colorectal cancer in ulcerative colitis: A meta-analysis. Gut 48: 526–535.
14. Farrell B. Godwin J. Richards S. Warlow C. (1991) The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: Final results. J Neurol Neurosurg Psychiatry 54: 1044–1054.
15. Ferrari P. Jenab M. Norat T. Moskal A. Slimani N. Olsen A. et al (2007) Lifetime and baseline alcohol intake and risk of colon and rectal cancers in the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer 121: 2065–2072.
16. Gann P. Manson J. Glynn R. Buring J. Hennekensm C. (1993) Low-dose aspirin and incidence of colorectal tumours in a randomized trial. J Natl Cancer Inst 85: 1220–1224.
17. Gillespie P. Chambers T. Chan K. Doronzo F. Morson B. Williams C. (1979) Colonic adenomas – a colonoscopy survey. Gut 20: 240–245.
18. Gonzalez C. Riboli E. (2010) Diet and cancer prevention: Contributions from the European Prospective Investigation into Cancer and Nutrition (EPIC) Study. Eur J Cancer 46: 2555–2562.
19. Greegor D.H. (1971) Occult blood testing for detection of asymptomatic colon cancer. Cancer 28: 131–134.
20. Hardcastle J. Chamberlain J. Robinson M. Moss S. Amar S. Balfour T. et al (1996) Randomised controlled trial of faecal-occult blood screening for colorectal cancer. Lancet 348: 1472–1477.
21. Hewitson P. Glasziou P. Watson E. Towler B. Irwig L. (2008) Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): An update. Am J Gastroenterol 103: 1541–1549.
22. Hoff G. Grotmol T. Skovlund E. Bretthauer M. and for the Norwegian Colorectal Cancer Prevention Study (2009) Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: Randomised controlled trial. BMJ 338: 1363–1366.
23. Imperiale T. Ransohoff D. Itzkowitz S. Turnbull B. Ross M. and Colorectal Cancer Study Group (2004) Fecal DNA versus fecal occult blood for colorectal cancer screening in an average-risk population. N Engl J Med 351: 2704–2714.
24. Jenab M. Bueno-de-Mesquita H. Ferrari P. van Duijnhoven F. Norat T. Pischon T. et al (2010) Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations: a nested case–control study. BMJ 340: b5500–b5500.
25. Jenkins P.B.M. (2001) Clinical perspective: Acromegaly and cancer: A problem. J Clin Endocrinol Metabol 86: 2935–2941.
26. Johnson C. Chen M. Toledano A. Heiken J. Dachman A. Kuo M. et al (2008) Accuracy of CT colonography for detection of large adenoma and cancers. New Engl J Med 359: 1207–1217.
27. Kewenter J. Brevinge H. Engaras B. Hagland E. Ahren C. (1994) Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing. Scand J Gastroenterol 29: 468–473.
28. Kronborg O. Fenger C. Olsen J. Jorgensen O.S.O. (1996) Randomised study of screening for colorectal cancer with faecal occult-blod test. The Lancet 348: 1467–1471.
29. Larsson S. Wolk A. (2006) Meat consumption and risk of colorectal cancer: A meta-analysis of prospective studies. Int J Cancer 119: 2657–2664.
30. Mandel J. Bond J. Church T. Snover D. Bradley G. Schuman L. et al (1993) Reducing mortality from colorectal cancer by screening for fecal occult blood. New Engl J Med 328: 1365–1371.
31. Manning A. Williams A.C. Game S.G. Paraskeva C. (1991) Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor beta (TGF beta): Conversion of an adenoma cell line to a tumorgenic phenotype is accompanied by a reduced response to inhibitory effects of TGF-beta. Oncogene 6: 1471–1476.
32. Morson B. (1974) The polyp-cancer sequence in the large bowel. Proc Roy Soc Med 67: 451–457.
33. Mowat C. Cole A. Windsor A.A.T. Arnott I. Driscoll R. Mitton S.O.T. et al on behalf of the IBD Section of the British Society of Gastroenterology (2011) Guidelines for the management of inflammatory bowel disease in adults. Gut 60: 571–607.
34. Muto T.B.H. Morson B. (1975) The evolution of cancer of the colon and rectum. Cancer 36: 2251–2270.
35. Norat T. Bingham S. Ferrari P. Slimani N. Jenab M. Mazuir M. et al (2005) Meat, fish, and colorectal cancer risk: The European Prospective Investigation into cancer and nutrition. J Natl Cancer Inst 97: 906–916.
36. O'Brien M. Winawer S. Zauber A. Gottlieb L. Sternberg S.D.B. et al (1990) The National Polyp Study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology 98: 371–379.
37. Park Y. Hunter D. Spiegelman D. Bergkvist L. Berrino F. van den Brandt P.A. (2005) Dietary fibre intake and risk of colorectal cancer – a pooled analysis of prospective cohort studies. JAMA 294: 2849–2857.
38. Peto R. Gray R. Collins R. Wheatley K. Hennekens C. Jamrozik K. et al (1988) Randomised trial of prophylatic daily aspirin in British male doctors. Br Med J (Clin Res Ed) 296: 313–316.
39. Pickhardt P. Choi J. Hwang I. Butler J. Puckett M. Hildebrandt H. et al (2003) Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. New Engl J Med 349: 2191–2200.
40. Rex D. Cutler C. Lemmel G. Rahmani E. Clark D. Helper D. et al (1997 a) Colonoscopic miss rates of adenomas determined by back-back colonoscopies. Gastroenterology 112: 24–28.
41. Rex D. Rahmani E. Haseman J. Lemmel G. Kastor S. Buckely J. (1997 b) Relative sensitivity of colonoscopy and barium eneman for detection of colorectal cancer in clinical practice. Gastroenterology 112: 17–23.
42. Rothwell P. Wilson M. Elwin C.-E. Norrving B. Algra A. Warlow C. et al (2010) Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. The Lancet 376: 1741–1750.
43. Segnan N. Senore C. Andreoni B. Aste H. Bonelli L. Crosta C. et al (2002) Baseline findings of the Italian multicentre randomised controlled trial of ‘once-only sigmoidsocopy’ – SCORE. J Natl Cancer Inst 94: 1763–1772.
44. Shinya H. Wolf W. (1979) Morphology, anatomic distribution and cancer potential of colonic polyps. An analysis of 7 000 polyps endoscopically removed. Ann Surg 190: 679–683.
45. Snyder D. Heston J. Meigs J. Flannery J. (1977) Changes in site distribution of colorectal carcinoma in Connecticut, 1940–1973. Am J Dig Dis 22: 791–797.
46. Stryker S. Wolff B. Culp C. Libbe S. Ilstrup D. MacCarty R. (1987) Natural history of untreated colonic polyps. Gastroenterology 93: 1009–1013.
47. Weissfeld J. Schoen R. Pinsky P. Bresalier R. Church T. Yurgalevitch S. et al (2005) Flexible sigmoidoscopy in the PLCO Cancer Screening Trial: Results from the baseline screening examination of a randomised trial. J Natl Cancer Inst 97: 989–997.
48. Williams A. Harper S. Paraskeva C. (1990) Neoplastic transformation of a human colonic epithelial cell line: In vitro evidence for the adenoma to carcinoma sequence. Cancer Res 50: 4725–4730.
49. Winawer S. Zauber A. O'Brien M. Gottlieb L. Sternberg S. Stewart E. et al (1992) The National Polyp Study. Design, methods and characteristics of patients with newly diagnosed polyps. The National Polyp Study Workgroup. Cancer 70: 1236–1245.
50. Winawer S. Zauber A. O'Brien M. Ho M. Gottlieb L. Sternberg S. et al (1993) Randomised comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. N Eng J Med 328: 901–906.
51. World Health Organization (2010) Cancer fact sheet number 297. Geneva: World Health Organisation. http:///www.who.int/mediacentre/factsheets/fs297/en/index.html (accessed March 2011).